Evidence has demonstrated that CDK8 plays an oncogenic role in cancers, by stimulating epithelial-to-mesenchymal transition in pancreatic cancer [36], facilitating migration and invasion in prostate cancer [37], and promoting proliferation and metastasis in breast cancer [38], melanoma and colorectal cancers [33, 39]. This evidence concerns the gene CDK8 and prostate carcinoma.